|
|
|
Insider
Information: |
Szyman Catherine M |
Relationship: |
Director |
City: |
Minneapolis |
State: |
MN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
124,017 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,333,562 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
124,017 |
|
|
Total
Value |
$2,333,562 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
52.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
CVP, Critical Care |
2024-05-07 |
76,992 |
2019-08-30 |
0 |
Premium* |
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
22,429 |
2020-05-27 |
0 |
Premium* |
|
Outset Medical, Inc. |
OM |
Director |
2023-05-31 |
24,596 |
2021-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
156 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-08-30 |
4 |
AS |
$222.00 |
$74,148 |
I/I |
(334) |
0 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-08-15 |
4 |
AS |
$214.53 |
$70,366 |
I/I |
(328) |
334 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-07-15 |
4 |
AS |
$191.70 |
$62,878 |
I/I |
(328) |
662 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-06-14 |
4 |
AS |
$184.55 |
$60,532 |
I/I |
(328) |
990 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-04-15 |
4 |
AS |
$192.00 |
$62,976 |
I/I |
(328) |
1,646 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-03-15 |
4 |
AS |
$179.10 |
$58,745 |
I/I |
(328) |
1,974 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-02-21 |
4 |
AS |
$176.34 |
$57,840 |
I/I |
(328) |
2,302 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2019-01-15 |
4 |
AS |
$155.00 |
$50,840 |
I/I |
(328) |
2,630 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2018-12-14 |
4 |
AS |
$162.66 |
$53,352 |
I/I |
(328) |
2,958 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2018-10-15 |
4 |
AS |
$142.64 |
$46,786 |
I/I |
(328) |
3,614 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2016-11-30 |
4 |
B |
$83.33 |
$328,487 |
I/I |
3,942 |
3,942 |
1.99 |
- |
|
OM |
Outset Medical, Inc. |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,747 |
6,747 |
0 |
- |
|
OM |
Outset Medical, Inc. |
Director |
|
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,288 |
10,035 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-04-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,987 |
10,768 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-05-14 |
4 |
AS |
$212.69 |
$237,362 |
D/D |
(1,116) |
12,271 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care & Vascular |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
12,340 |
12,340 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,600 |
12,368 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-05-13 |
4 |
AS |
$216.93 |
$162,698 |
D/D |
(750) |
13,387 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-05-12 |
4 |
D |
$225.05 |
$153,484 |
D/D |
(682) |
14,137 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-04-16 |
4 |
AS |
$216.91 |
$242,072 |
D/D |
(1,116) |
14,755 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-05-11 |
4 |
D |
$217.84 |
$762,222 |
D/D |
(3,499) |
14,819 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-03-23 |
4 |
AS |
$162.95 |
$181,852 |
D/D |
(1,116) |
15,773 |
0 |
% |
|
NARI |
Inari Medical, Inc. |
Director |
|
2022-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,000 |
15,891 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-01-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
222 |
16,889 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-02-03 |
4 |
AS |
$219.50 |
$548,750 |
D/D |
(2,500) |
16,889 |
0 |
% |
|
156 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|